Tron Group Stock Price, News & Analysis
Company Description
Tron Group (OTC Link: TGRP) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $4.2M.
TGRP stock has gained 25.0% over the past year. Shares last traded at $0.0400.
This page provides a comprehensive overview of TGRP stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Tron Group (TGRP) stock last traded at $0.0400. Over the past 12 months, the stock has gained 25.0%. At a market capitalization of $4.2M, TGRP is classified as a micro-cap stock with approximately 184.0M shares outstanding.
Latest News
Tron Group has 6 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 0 with negative movement. Key topics include clinical trial, crypto, acquisition, partnership. View all TGRP news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Tron Group (TGRP) currently stands at 1.3 thousand shares, representing 0.1% of the float. Over the past 12 months, short interest has increased by 168.6%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Tron Group (TGRP) currently stands at 2.8 days, up 139.3% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has increased 180% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 2.8 days.
TGRP Company Profile & Sector Positioning
Tron Group (TGRP) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing TGRP often look at related companies in the same sector, including ASEP MED HLDGS INC (SEPSF), Nymox Pharm (NYMXF), Orgenesis Inc (ORGS), Kane Biotech Inc (KNBIF), and Biophytis Sa (BPTSY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate TGRP's relative position within its industry.